Clinical Trial Update: A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study evaluating the long-term safety of luspatercept in participants who have previously participated in other l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasm-associated Myelofibrosis

Drugs mentioned

• Luspatercept (luspatercept)

Snippet

Sponsor: Celgene | Conditions: Myelodysplastic Syndromes (MDS), Beta-thalassemia | Phase 3 | Status: RECRUITING